Aveo Pharmaceuticals Inc AVEO:NASDAQ

Last Price$6.50NASDAQ Previous Close - Last Trade as of 1:00PM ET 11/26/21

Today's Change-0.03(0.46%)
Bid (Size)$6.00 (10)
Ask (Size)$6.50 (11)
Day Low / High$6.29 - 6.57
Volume103.0 K

View Biotechnology IndustryPeer Comparison as of 11/26/2021


Aveo Pharmaceuticals Inc ( NASDAQ )

Price: $6.50
Change: -0.03 (0.46%)
Volume: 103.0 K
1:00PM ET 11/26/2021

aTyr Pharma Inc ( NASDAQ )

Price: $8.06
Change: -0.04 (0.49%)
Volume: 50.8 K
1:00PM ET 11/26/2021

Leap Therapeutics Inc ( NASDAQ )

Price: $2.54
Change: +0.22 (9.48%)
Volume: 2.0 M
1:00PM ET 11/26/2021

Aspira Women's Health Inc ( NASDAQ )

Price: $2.01
Change: -0.16 (7.37%)
Volume: 1.3 M
1:00PM ET 11/26/2021

Eiger BioPharmaceuticals Inc ( NASDAQ )

Price: $6.52
Change: -0.04 (0.61%)
Volume: 94.6 K
1:00PM ET 11/26/2021

Read more news Recent News

-- Earnings Flash (AVEO) AVEO ONCOLOGY Posts Q3 Revenue $15.2M, vs. Street Est of $13.8M
4:10PM ET 11/08/2021 MT Newswires


Aveo Pharmaceuticals' Head, Neck Cancer Drug Gets FDA Fast-Track Designation
9:23AM ET 9/20/2021 MT Newswires

Aveo Pharmaceuticals (AVEO) said Monday the US Food and Drug Administration granted ficlatuzumab, its investigational drug being developed for the...

-- Earnings Flash (AVEO) AVEO ONCOLOGY Reports Q2 Revenue $7.6M, vs. Street Est of $6.96M
4:17PM ET 8/05/2021 MT Newswires


--HC Wainwright Adjusts Price Target on AVEO Pharmaceuticals to $19 From $27, Keeps Buy Rating
7:23AM ET 7/12/2021 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Company Profile

Business DescriptionAVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA. View company web site for more details
Address30 Winter Street
Boston, Massachusetts 02108
Number of Employees17
Recent SEC Filing11/08/202110-Q
President, Chief Executive Officer & DirectorMichael P. Bailey
Chief Financial OfficerErick J. Lucera
Vice President-Information TechnologyMatthew Coulter
Head-ComplianceStefanie Solomon

Company Highlights

Price Open$6.33
Previous Close$6.53
52 Week Range$4.95 - 18.24
Market Capitalization$223.4 M
Shares Outstanding34.4 M
SectorHealth Technology
Next Earnings Announcement03/15/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$1.98
Beta vs. S&P 500N/A
Revenue$5.4 M
Net Profit Margin-225.54%
Return on Equity-105.10%

Analyst Ratings as of 11/06/2020

Consensus RecommendationConsensus Icon
Powered by Factset